Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.

@article{Harenberg1990RandomizedCS,
  title={Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.},
  author={Job Harenberg and Bettina Kallenbach and Una Martin and Carl Erik Dempfle and Rainer Zimmermann and Wolfgang Kuebler and Dieter L. Heene},
  journal={Thrombosis research},
  year={1990},
  volume={59 3},
  pages={639-50}
}
166 patients aged 40-80 years were included in a controlled, randomized, double-blind study to determine the efficacy and safety of a single daily injection of a low molecular weight (LMW) heparin for prevention of deep-vein thrombosis compared to low dose conventional heparin. Patients received 1 x 1.500 aPTT units of a LMW heparin fraction (plus 2 x placebo injection) or 3 x 5.000 IU of an unfractionated heparin. During 10 days of treatment, patients underwent repeated clinical investigation… CONTINUE READING
18 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…